Core Insights - The analysis focuses on various stock options and their corresponding derivatives, aiming to provide investors with clearer choices based on market conditions and stock performance [1] Stock Analysis ZTE Corporation (00763) - ZTE's stock price experienced a sharp decline last week but showed recovery on Monday, closing at HKD 39.96, leading some investors to consider a bullish opportunity [2] - Technical signals indicate a "neutral" state, making it difficult to assess the suitability of available options [2][3] - Only one call option is available with a strike price of approximately HKD 45, which complicates the comparison of terms [2] - Other options with strike prices of HKD 57 are available, but they are considered too high compared to the current stock price [3] Lao Poo Gold (06181) - Lao Poo Gold's stock has shown strong performance recently, closing at HKD 798, down from previous highs [5] - Conservative investors may wait for a price drop to around HKD 650 before considering investment [5] - There are only two put options available, both with high strike prices compared to the current stock price, suggesting a lack of suitable products [6] China Life Insurance (02628) - China Life's stock rose by 2.44% to close at HKD 23.52, with investors optimistic about further increases [7] - There are seven call options available with strike prices between HKD 23.6 and HKD 25, which are relatively close to the current price [7][8] - One option has a leverage of 6.5 times, but it also has a higher implied volatility of 44.1% [8] Hengan International (01044) - Hengan's stock has been on an upward trend, with expectations of reaching HKD 30 [10] - Only one call option is available with a strike price of approximately HKD 30.88, making it challenging to evaluate its terms [10] Mengniu Dairy (02319) - Mengniu's stock price rebounded to HKD 72.1 after a previous drop, attracting both bullish and bearish sentiments from investors [13][14] - There are multiple call options available with strike prices around HKD 73, offering high leverage of approximately 10 times [13][14] - Variability in implied volatility and time value decay among different options necessitates careful comparison [14][15] NetEase (09999) - NetEase's stock is performing well, with investors considering related bull certificates [18] - A focus on the recovery price is essential, with suitable options available below HKD 219 [18][19] Zhaojin Mining (01818) - Zhaojin's stock price has declined to HKD 30.52, leading many investors to consider exiting [22] - The lack of available put options limits strategies for bearish investors [22] Conclusion - The analysis highlights the importance of comparing available derivatives for various stocks to make informed investment decisions, emphasizing the need for multiple options to assess suitability effectively [20]

Market Performance - The Hang Seng Index opened 101 points higher on the 27th, rose 129 points to a high of 25,653 points in the early session, then fell back, and closed down 323 points or 1.3% at 25,201 points [1] - The H-shares Index fell 128 points or 1.4% to close at 9,020 points, and the Hang Seng Tech Index fell 84 points or 1.5% to close at 5,697 points [1] - The total turnover of the market increased to HK$371.376 billion, the highest in nearly four months [1] - A-share market opened slightly higher, the ChiNext Index once rose more than 2%, but all three major indices fell in the afternoon. The Shanghai Composite Index closed down 68 points or 1.8% at 3,800 points, with a turnover of RMB 1.33 trillion; the Shenzhen Component Index closed down 178 points or 1.4% at 12,295 points, with a turnover of RMB 1.84 trillion; the ChiNext Index closed down 18 points or 0.7% at 2,723 points, with a turnover of RMB 878.3 billion [2] - In the US stock market on Wednesday, the Nasdaq rose 45 points or 0.2% to 21,590 points, the S&P 500 Index rose 15 points or 0.2% to 6,481 points, and the Dow Jones Industrial Average rose 147 points or 0.3% to 45,565 points [2] Central Bank Operations - The People's Bank of China conducted RMB 379.9 billion of seven-day reverse repurchase operations on the 27th, with the operating rate remaining unchanged at 1.4%. There were RMB 616 billion of reverse repurchases maturing, resulting in a net withdrawal of RMB 236.1 billion [2] - The central parity rate of the RMB against the US dollar was raised by 80 points to 7.1108 [2] Company Earnings - Ctrip Group - S (09961.HK) reported a turnover of RMB 28.714 billion for the six months ended June this year, up 16.2% year-on-year. Net profit was RMB 9.123 billion, up 12% year-on-year, and non-GAAP net profit was also RMB 9.123 billion, up 12% year-on-year. Earnings per share were RMB 13.82. No dividend was declared [3] - Maogeping (01318.HK) reported revenue of RMB 2.588 billion for the six months ended June, up 31.3% year-on-year; gross profit was RMB 2.179 billion, up 30.2%. Net profit was RMB 670 million, up 36.1%, and earnings per share were RMB 1.37. No dividend was declared [4] - China Mengniu Dairy Company Limited (02319.HK) reported revenue of RMB 41.567 billion for the six months ended June, down 6.9% year-on-year due to the oversupply of raw milk and the slower-than-expected recovery of demand. Net profit was RMB 2.046 billion, down 16.4%, and earnings per share were 52.3 cents. No dividend was declared [4] - People's Insurance Company (Group) of China, Ltd. (01339.HK) reported total operating income of RMB 324.122 billion for the six months ended June this year, up 10.9% year-on-year. Net profit was RMB 26.671 billion, up 14% year-on-year, and earnings per share were RMB 0.6. An interim cash dividend of RMB 0.075 per 10 shares was declared, compared with RMB 0.063 per 10 shares in the same period last year [4] - Innovent Biologics, Inc. (01801.HK) reported revenue of RMB 5.953 billion for the six months ended June this year, up 50.6% year-on-year. It turned from a loss to a profit of RMB 834 million, compared with a loss of RMB 393 million in the same period last year. Earnings per share were RMB 0.51. No dividend was declared. Non-IFRS profit was RMB 1.213 billion, compared with a loss of RMB 160 million last year; non-IFRS EBITDA was RMB 1.413 billion, compared with a loss of RMB 161 million last year [5] - Meituan (03690.HK) reported a profit of RMB 365 million for the second quarter ended June 2025, down 96.8% year-on-year. Non-IFRS adjusted EBITDA was RMB 2.782 billion, down 81.5% year-on-year, and adjusted net profit fell 89% to RMB 1.493 billion. Revenue in the second quarter was RMB 91.84 billion, up 11.7% year-on-year, slightly lower than the forecast range of RMB 92.067 billion to RMB 94.534 billion by 8 brokers [5]